Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07422584

Cytokine Response to Abdominal Wall Reconstruction

This is a prospective, observational translational study of patients undergoing major abdominal wall reconstruction with primary fascial closure. The project integrates perioperative cytokine profiling, direct measurement of intra-abdominal pressure, and detailed clinical outcomes to define the biologic and physiologic consequences of high-tension closure.

The study includes three cohorts: 1) Healthy controls (N=5), 2) High-tension fascial closure AWR patients (N=10), 3) Low-tension fascial closure AWR patients (N=10). Fascial closure tension will not be altered for the purpose of the study and will be determined by the operating surgeon as part of routine clinical decision-making.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Northwestern Memorial Hospital

Chicago, Illinois, 60611, United States

Location status: Recruiting

Location contact

Megan Melland-Smith, MD

CONTACT

[email protected]

312-907-1414

Michael Rosen, MD

SUB_INVESTIGATOR

Nancy Ly, MD

CONTACT

[email protected]

262-455-1560

Steven Schwulst, MD

SUB_INVESTIGATOR

About this study

Major abdominal wall reconstruction (AWR) for large ventral hernias is among the most physiologically demanding procedures performed in general surgery. These patients often have a history of multiple prior abdominal operations, chronically altered abdominal wall mechanics and significant loss of domain. Reduction of visceral contents and abdominal wall reconstruction frequently require high-tension closure, resulting in an abrupt increase in intra-abdominal pressure (IAP) that impairs diaphragmatic excursion, reduces splanchnic perfusion, causes renal venous congestion and induces global physiologic stress. Consequently, these patients face a high risk of postoperative complications including respiratory failure, renal dysfunction, and prolonged intensive care unit (ICU) stays.

A critical gap in AWR research is the lack of characterization of the biologic inflammatory and cytokine responses associated with high-tension abdominal wall closure. This gap stands in contrast to robust evidence from the trauma and critical care literature demonstrating that cytokine activation correlates with injury severity and contributes to organ dysfunction and postoperative morbidity.

Defining the inflammatory and cytokine signaling pathways activated during high-tension closure would provide a framework to inform operative planning and perioperative management, particularly in patients with significant comorbidities who may be less tolerant to postoperative physiologic stress. These insights would enable validation of current techniques and establish the foundation for future interventional trials targeting inflammatory pathways to improve postoperative outcomes. The Digestive Health Institute at Northwestern University is uniquely positioned to support this translational research, bridging surgical physiology, inflammation, and patient outcomes.

The investigators hypothesize that:

  • Major abdominal wall reconstruction induces a trauma-like systemic inflammatory response characterized by elevations in GM-CSF, IFN-Gamma, IL-1, IL-2, IL-5, IL-6, IL-8, and TNF-alpha with a concomitant decrease in the anti-inflammatory cytokines, IL-4 and IL-10.
  • Increased intra-abdominal pressure (IAP) following high-tension closure amplifies cytokine activation and is associated with early postoperative organ dysfunction and increased postoperative complications.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Surgical Participants

  • Adults aged 18 years or older
  • Scheduled to undergo open retromuscular ventral hernia repair
  • Able to provide written informed consent Healthy Control Participants
  • Adults aged 18 years or older
  • No known inflammatory, autoimmune, or immunologic disease
  • Able to provide written informed consent

Exclusion criteria

  • Emergent or urgent cases
  • Pregnancy
  • Chronic systemic steroid use or immunosuppressive therapy
  • Active infection at the time of enrollment
  • Known autoimmune or inflammatory disease
  • End-stage organ failure
  • Abdominal surgery within the preceding 60 days

Treatment and study plan

Not applicable- observational study

Other

There are no interventions in this observational study.

Primary outcomes

  1. Determine whether fascial closure tension correlates with systemic and peritoneal fluid cytokine activation.

    Time frame: Baseline through postoperative day 5

    Blood and peritoneal fluid will be collected at baseline (intra-operative), immediately following fascial closure and on postoperative days 1, 3, and 5. Serum cytokine concentrations of GM-CSF, IFN-gamma, IL-1, IL-2, IL-5, IL-6, IL-8, and TNF-alpha (inflammatory); IL-4 and IL-10 (anti-inflammatory) will be measured via multiplex immunoassays (Luminex). Cytokine area under the curve will also be calculated to allow analysis of total cytokine exposure over time.

Secondary outcomes

  1. Differences in peripheral blood mononuclear cells and peritoneal macrophage transcriptomic signatures via bulk RNA sequencing between baseline profiles from healthy control subjects, high-tension and low-tension abdominal wall closures.

    Time frame: Baseline through postoperative day 5

    Peripheral blood mononuclear cells (PBMCs) and peritoneal macrophages will be isolated at baseline, immediately following fascial closure and on postoperative days 1, 3, and 5. Bulk RNA sequencing will be performed. Differentially expressed genes will be determined and KEGG and GO pathway analyses performed.

  2. Differences in peak intra-abdominal values, intra-abdominal hypertension grading, abdominal perfusion pressure, plateau pressure between baseline profiles from healthy control subjects, high-tension and low-tension abdominal wall closures.

    Time frame: Baseline through postoperative day 5

    Intra-abdominal pressure (IAP) will be assessed using bladder pressure measurements, along with plateau pressure and abdominal perfusion pressure (APP) - calculated as mean arterial pressure (MAP) minus IAP. Measurements will be obtained at baseline, POD1, POD3 and POD5. Measures will include peak IAP, and duration of intra-abdominal hypertension (IAH), defined as IAP >12mmHg. Peak serum cytokine levels will be correlated with peak IAP using Spearman correlation and multivariable linear regression.

  3. Incidence of respiratory compromise

    Time frame: From surgery through hospital discharge (up to 30 days)

    Respiratory compromise defined as failure to wean from mechanical ventilation or development of postoperative pneumonia.

  4. Incidence of acute kidney injury

    Time frame: From surgery through hospital discharge (up to 30 days)

    Acute kidney injury defined as increase in serum creatinine to >1.5 times baseline with urine output <0.5 mL/kg/hr for 6 hours.

  5. Incidence of vasopressor use

    Time frame: From surgery through hospital discharge (up to 30 days)

    Requirement for vasopressor support postoperatively.

  6. Incidence of postoperative ileus

    Time frame: From surgery through hospital discharge (up to 30 days)

    Development of postoperative ileus as documented in the medical record.

  7. Incidence of wound complications

    Time frame: From surgery through hospital discharge (up to 30 days)

    Development of surgical site infection or wound dehiscence

  8. ICU length of stay

    Time frame: From surgery through hospital discharge (up to 30 days)

    Number of days in the intensive care unit following surgery.

  9. Hospital length of stay

    Time frame: From surgery through hospital discharge (up to 30 days)

    Total number of days hospitalized following surgery.

Study contacts

Contact information is provided by the study sponsor or research team.

Megan Melland-Smith, MD

CONTACT

[email protected]

312-907-1414

Nancy Ly, MD

CONTACT

[email protected]

262-455-1560

Sponsors and collaborators

Lead sponsor

Northwestern University

Other

Registry information

Official study title

Pilot Study of Systemic Inflammatory and Transcriptomic Responses in Patients Undergoing Open Retromuscular Ventral Hernia Repair

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Feb 20, 2026
Registry last updated
Feb 20, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.